User Manual
Table Of Contents
- 1. General description
- 2. Indications
- 3. Contraindications
- 4. Warnings and precautions
- 5. Adverse events
- 6. Clinical studies
- 7. Patient selection and treatment
- 8. Patient counselling information
- 9. Conformance to standards
- 10. Physician guidelines
- 11. Patient information
- 12. How supplied
- 13. Device description
- 14. Implant procedure
- 14.1. Necessary equipment
- 14.2. Packaging
- 14.3. Optional equipment
- 14.4. Before opening the package
- 14.5. Prior to implantation
- 14.6. Device placement
- 14.7. Choosing the type of lead
- 14.8. Shock configuration (+ -> -)
- 14.9. Measurement of thresholds at implant
- 14.10. Lead connection
- 14.11. Device implantation
- 14.12. Tests and programming
- 15. Special modes
- 16. Main functions
- 17. Patient follow-up
- 18. Physical characteristics
- 19. Electrical characteristics
- 20. Programmable parameters
- 21. Non programmable parameters
- 22. Limited warranty
- 23. Patents
- 24. Explanation of symbols

5. ADVERSE EVENTS
Event # of Patients* % of Patients # of Events Events/100
Device-
Years**
Change in ventricular sensing
threshold
1 2.6 1° 5.2
Device reset*** 1 2.6 1° 5.2
Inappropriate therapy for EMI 1 2.6 1° 5.2
Pneumothorax 1 2.6 1° 5.2
Pocket hematoma 2 5.3 2° 10.5
Pocket infection/hematoma 1 2.6 1° 5.2
Pocket infection from previous
pacemaker
1 2.6 1° 5.2
Prolonged implant procedure 1 2.6 1 5.2
Sensor acceleration during
telemetry***
1 2.6 1 5.2
Shock for VT in VF Zone 1 2.6 1° 5.2
Slow VT not converted by ATP
therapy
1 2.6 2° 10.5
Unsatisfactory sensing
threshold test***
2 5.3 2 10.5
Ventricular oversensing 3 7.9 3 15.7
* A patient can have more than one observation.
** There were 228.7 device months in this study.
***These observations would not have happened with the currently marketed device and
programmer.
°Investigator indicated that Defender IV DR did not cause or contribute to the event.
14
SORIN – INTENSIA VR 124 – U153A